These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 21823254

  • 1. Insulin pens: the modern delivery devices.
    Baruah MP.
    J Assoc Physicians India; 2011 Apr; 59 Suppl():38-40. PubMed ID: 21823254
    [Abstract] [Full Text] [Related]

  • 2. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL, Ignaut DA, Bodie JN.
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [Abstract] [Full Text] [Related]

  • 3. A review of insulin pen devices.
    McCoy EK, Wright BM.
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [Abstract] [Full Text] [Related]

  • 4. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T, Edelman S, Walter C, Lecointre B, Spollett G.
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [Abstract] [Full Text] [Related]

  • 5. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R, de Beaufort C, Hoey H, Anderson B.
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [Abstract] [Full Text] [Related]

  • 6. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
    Bailey T, Campos C.
    Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783
    [Abstract] [Full Text] [Related]

  • 7. Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.
    Oyer D, Niemeyer M, Moses A.
    Postgrad Med; 2012 Sep; 124(5):110-20. PubMed ID: 23095431
    [Abstract] [Full Text] [Related]

  • 8. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K, Ory C, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E.
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [Abstract] [Full Text] [Related]

  • 9. Addressing barriers to insulin therapy: the role of insulin pens.
    Magwire ML.
    Am J Ther; 2011 Sep; 18(5):392-402. PubMed ID: 20838202
    [Abstract] [Full Text] [Related]

  • 10. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA, Schwartz SL, Sarwat S, Murphy HL.
    Diabetes Educ; 2009 Sep; 35(5):789-98. PubMed ID: 19783767
    [Abstract] [Full Text] [Related]

  • 11. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use.
    Perfetti R.
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S79-85. PubMed ID: 20515312
    [Abstract] [Full Text] [Related]

  • 12. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T, Hohberg C, Pfützner AH, Jørgensen C, Jensen KH, Pfützner A.
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [Abstract] [Full Text] [Related]

  • 13. FlexPen for the delivery of insulin: accuracy, injection force and patient preference.
    Pfützner A.
    Expert Rev Med Devices; 2009 Mar; 6(2):115-23. PubMed ID: 19298158
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M, Bell D, Jacobsen C, Suwannasari R, FlexPen Study Team.
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [Abstract] [Full Text] [Related]

  • 15. Overview of insulin delivery pen devices.
    Kroon L.
    J Am Pharm Assoc (2003); 2009 Nov; 49(5):e118-31. PubMed ID: 19692314
    [Abstract] [Full Text] [Related]

  • 16. [Insulin pens for treatment of diabetes].
    Bärtsch U, Comtesse Ch, Wetekam B.
    Ther Umsch; 2006 Jun; 63(6):398-404. PubMed ID: 16841576
    [Abstract] [Full Text] [Related]

  • 17. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.
    Nadeau DA, Campos C, Niemeyer M, Bailey T.
    Curr Med Res Opin; 2012 Jan; 28(1):3-13. PubMed ID: 22114905
    [Abstract] [Full Text] [Related]

  • 18. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients.
    Lee IT, Liu HC, Liau YJ, Lee WJ, Huang CN, Sheu WH.
    J Eval Clin Pract; 2009 Aug; 15(4):699-703. PubMed ID: 19674222
    [Abstract] [Full Text] [Related]

  • 19. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK.
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [Abstract] [Full Text] [Related]

  • 20. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A, Spollett G.
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.